allowing us to progress re-dosable gene therapies with drug titration capabilities and engineered tropism to reach the targeted cells whatever the size of the gene involved.
In vitro In vivo
Tyris proprietary oDNA™ is an unprecedented synthetic linear closed DNA format.
what is it?
Our oDNA™ are only made of the transgene (e.g. gene of interest, promoter, enhancer) and other key sequences if required (e.g. ITRs), along with our proprietary adaptors.
What does it do?
Provides a unique differentiation over plasmid and other DNA formats, since it can be uniquely optimized on a project basis for achieving an unprecedented modulation and enhancement of desired transgene properties.
Non-Viral delivery technology
Provides versatile nanosized 3D architecture and broad functionality possibilities.